Prawo i regulacje · 01/02/2012

U.S. Federal Trade Commission Approves Pfizer's Acquisition of BioNTech, a German Biotechnology Company Developing COVID-19 Vaccines

The U.S. Federal Trade Commission has approved Pfizer's acquisition of BioNTech, a German biotechnology company developing COVID-19 vaccines, after a thorough review of the deal's impact on the market and competition, according to a recent decision and order issued by Randall L. Wolff, M.D., a U.S. Federal Trade Commission official.